
Daniel A Rothenberg, PhD
@aspalaargphd
Proteomics/Immunopeptidomics for @BioNTech_Group. Alum of @MITdeptofBE and @UTBiomedical. Tweets are my own opinions. Random sports ranting at @drothenberg0121
ID: 1536232099207782400
13-06-2022 06:21:41
45 Tweet
123 Takipçi
200 Takip Edilen







Click chemistry and bioorthogonal labeling approaches pioneered by Carolyn Bertozzi were key technologies that enabled my PhD thesis. It’s awesome to see it get recognized with the The Nobel Prize today


We and Pfizer Inc. started a Phase 1 trial for #BNT162b4 aimed at enhancing the breadth of t cell responses. This is part of our next generation #COVID19 vaccine candidate approach. Goal: potentially broaden and extend the duration of protection against COVID-19.





Happy to share some of the innovative work at BioNTech SE. It's been amazing to have an insider perspective on the development of T cell-directed vaccine tech -- always thinking about ways to manipulate the T cell synapse to modulate immunity! cell.com/cell/fulltext/…





New insights into overcoming immune deserts in tumors @tronmainz BioNTech SE. Read our digest here 👉 bit.ly/43t3LDl

